Biotechnology
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline
SINGAPORE, July 10, 2019 /PRNewswire/ -- Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capit...
2019-07-10 15:09
2800
Accutest Biologics Private Limited (ABPL) Receives the Prestigious OECD-Good Laboratory Practice (GLP) Certification, a First-of-its-kind in India
MUMBAI, India, July 9, 2019 /PRNewswire/ -- India-based Accutest Biologics Private Limited (ABPL), a leading CRO for high-quality Biochemical characterization and Bioanalytical services supporting preclinical and clinical development of Biologics and Biosimilars, has received the prestigious OEC...
2019-07-09 14:30
2643
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
MELBOURNE, Australia, July 6, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch ofGene Therapy in Hemophilia: An ISTH Education Initiative. This landmark launch, the first of its kind in hemophilia, will take place duri...
2019-07-06 06:00
3300
NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study
LUND, Sweden, 4 July 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has initiated the second part in its ongoing Phase Ia/b clinical study with KL1333, NeuroVive's candidate drug for chronic treatment of genetic mitochondri...
2019-07-04 21:05
8559
New England Biolabs®, Inc. opens eighth subsidiary in Australia
IPSWICH, Massachusetts, July 4, 2019 /PRNewswire/ -- New England Biolabs (NEB® ), a world leader in the production of reagents for the life science industry, extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd. Australia's Life Sciences industry is hom...
2019-07-03 22:00
2234
Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2019
HONG KONG, July 3, 2019 /PRNewswire/ -- Gilead Sciences, Inc. today announced the launch of the 2019 Gilead Asia Pacific Rainbow Grant program, a grant initiative that supports community-led programs for people living with HIV in theAsia Pacific region. Non-governmental or advocacy organizations ...
2019-07-03 18:13
2724
A2A Pharmaceuticals Appoints Dr. Sotirios Stergiopoulos Chief Executive Officer
NEW YORK, July 3, 2019 /PRNewswire/ -- A2A Pharmaceuticals Inc. (A2A), a biotechnology company committed to the advancement of innovative scientific research and new therapeutic agents, today announced the appointment of Dr. Sotirios G. Stergiopoulos as President and Chief Executive Officer. He ha...
2019-07-03 04:28
2606
Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation
KIRKLAND, Washington, July 1, 2019 /PRNewswire/ -- Cardiac Dimensions®, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the Carillon Mitral Contour System® has been implanted in 1,0...
2019-07-01 19:10
1400
WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies
SHANGHAI, June 29, 2019 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company, announces that it has been selected as one of MIT Technology Review's 50 Smartest Companies (TR50) for 2019. WuXi was chosen for its ded...
2019-06-29 13:26
10055
NMPA Accepts New Drug Application for IBI301, a Biosimilar Product Candidate of Rituximab (MabThera/Rituxan)
SUZHOU, China, June 27, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801) and Eli Lilly and Company ("Lilly") jointly announced today that the National Medical Products Administration (NMPA) has accepted its new drug application (NDA) for IBI301, a co-developed biosimilar pro...
2019-06-27 12:21
11352
Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors
BEIJING, June 27, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that it has received Investigational New Drug (IND) cleara...
2019-06-27 09:00
2623
ISTH 2019 Congress: Top Global Experts Convene in Melbourne to Showcase Latest Science and Research
MELBOURNE, June 26, 2019 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH) will recognize its landmark 50th anniversary as the leader in the field of thrombosis and hemostasis at theISTH 2019 Congress fromJuly 6-10 in Melbourne, Australia. Under the congress theme of ...
2019-06-26 20:00
1516
Purecircle Holdings Announces Name Change to Pure CE
SINGAPORE, June 26, 2019 /PRNewswire/ -- Pure CE Pte Ltd, formerly Purecircle Holdings Pte Ltd today announced that it changed its corporate name from "Purecircle Holdings" to "Pure CE". Pure CE updated its corporate name and branding to better reflect its identity as a leading private equi...
2019-06-26 17:21
2979
Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies
SHANGHAI and NEW YORK, June 24, 2019 /PRNewswire/ -- Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma and device companies capitalize on the rapid internationalization of clinical trials between the US andChina while maintain...
2019-06-25 04:00
2108
Thailand presents the Benefits of Cold Pressed Virgin Rice Bran Oil
BANGKOK, June 24, 2019 /PRNewswire/ -- The Department of Foreign Trade, Ministry of Commerce,Thailand, has introduced a project called "Think RICE, ThinkTHAILAND" to encourage international community to pay attention to consumer health and to raise awareness on the national crop by providing a w...
2019-06-24 20:00
2304
FDA Grants Orphan Drug Designation to XW Laboratories' XWL-008 for the Treatment of Patients with Narcolepsy
WUHAN, China, June 24, 2019 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a clinical-stage biopharmaceutical company pioneering the discovery of novel small molecule therapeutics for the treatment of neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has gr...
2019-06-24 17:00
3250
Asieris Announces Completion of Enrollment for its US APL-1202 Phase Ib Clinical Trial
SHANGHAI, June 24, 2019 /PRNewswire/ -- Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, announced today the completion of enrollment for its APL-1202 Phase Ib trial in the US....
2019-06-24 09:00
2157
Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019
SEOUL, South Korea, June 21, 2019 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered inSouth Korea, announced that it has completed the FDA registration of its nucleic acid extraction instrument, the Seegene STARlet, and will begin offering t...
2019-06-21 20:00
2122
Gracell Data on Multi-center Investigation of FasT CAR-19 Therapy Shows Positive First Impact in Patients with Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
- Preliminary data shows a high response rate, with 16 of 16 patients achieving complete remission and 14 of 16 patients achieving undetectable minimal residual disease with mild side effect observed - FasT CAR-19 (GC007F) can be manufactured overnight with 100% success - FasT CAR-19 is expecte...
2019-06-21 08:00
3426
SPIE To Acquire Photonex, UK's Top Photonics Exhibition
BELLINGHAM, Washington and CARDIFF, Wales, June 21, 2019 /PRNewswire/ -- SPIE, the international society for optics and photonics,has agreed to purchase Xmark Media, organizer of key UK photonics exhibitions. The acquisition expands SPIE activities inEurope, where its technical events are support...
2019-06-21 05:42
3261
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00
Most Read
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
5790
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
2024-04-22 16:00
4447
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
2024-04-22 06:00
4039
TCTM Filed 2023 Annual Report on Form 20-F
2024-04-20 05:48
3320
Dingdong Files Its Annual Report on Form 20-F
2024-04-20 05:00
3064